You can find the annual or quarterly income statement of Kyverna Therapeutics Inc here for insights into the performance and operational efficiency of Kyverna Therapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q1

FY2022Q4

Total revenue

----

-100.00%0.00

----

--282.00K

Revenue

----

-100.00%0.00

----

--282.00K

Operating expenses

-0.11%38.73M

32.82%44.41M

59.44%46.81M

91.99%41.04M

--38.77M

--33.44M

156.51%29.36M

136.03%21.38M

--11.45M

--9.06M

R&D expenses

4.33%30.46M

31.09%35.82M

66.55%37.43M

95.09%33.48M

--29.19M

--27.32M

158.02%22.48M

142.86%17.16M

--8.71M

--7.07M

Depreciation, depletion, and amortization

-18.64%454.00K

0.00%537.00K

-6.70%501.00K

6.03%563.00K

--558.00K

--537.00K

36.29%537.00K

41.98%531.00K

--394.00K

--374.00K

Other operating expenses

--0.00

---600.00K

----

Operating profit

0.11%-38.73M

-32.82%-44.41M

-59.44%-46.81M

-91.99%-41.04M

---38.77M

---33.44M

-156.51%-29.36M

-143.61%-21.38M

---11.45M

---8.78M

Net non-operating interest income (expenses)

Non-operating interest income

-54.09%2.00M

-49.64%2.36M

3.29%2.83M

353.11%3.58M

--4.36M

--4.69M

683.67%2.73M

165.66%789.00K

--349.00K

--297.00K

Non-operating interest expense

-78.79%7.00K

-64.10%14.00K

-43.18%25.00K

-42.55%27.00K

--33.00K

--39.00K

0.00%44.00K

14.63%47.00K

--44.00K

--41.00K

Special income (expenses)

--0.00

---600.00K

----

Other non-operating income (expenses)

-17.78%-53.00K

8.70%-21.00K

-3.85%-27.00K

112.50%4.00K

---45.00K

---23.00K

-766.67%-26.00K

-239.13%-32.00K

---3.00K

--23.00K

Income before tax

-6.65%-36.79M

-46.10%-42.08M

-67.22%-44.63M

-81.40%-37.49M

---34.49M

---28.80M

-139.55%-26.69M

-143.26%-20.67M

---11.14M

---8.50M

Income after tax

-6.65%-36.79M

-46.10%-42.08M

-67.22%-44.63M

-81.40%-37.49M

---34.49M

---28.80M

-139.55%-26.69M

-143.26%-20.67M

---11.14M

---8.50M

Net income from continuous operations

-6.65%-36.79M

-46.10%-42.08M

-67.22%-44.63M

-81.40%-37.49M

---34.49M

---28.80M

-139.55%-26.69M

-143.26%-20.67M

---11.14M

---8.50M

Net income attributable to controlling interests

-6.65%-36.79M

-46.10%-42.08M

-67.22%-44.63M

-81.40%-37.49M

---34.49M

---28.80M

-139.55%-26.69M

-143.26%-20.67M

---11.14M

---8.50M

Net income attributable to common shareholders

-6.65%-36.79M

-46.10%-42.08M

-67.22%-44.63M

-81.40%-37.49M

---34.49M

---28.80M

-139.55%-26.69M

-143.26%-20.67M

---11.14M

---8.50M

Basic earnings per share

-6.02%-0.85

-45.76%-0.97

-66.83%-1.03

-109.77%-0.87

---0.80

---0.67

-126.81%-0.62

-98.63%-0.41

---0.27

---0.21

Diluted earnings per share

-6.02%-0.85

-45.76%-0.97

-66.83%-1.03

-109.77%-0.87

---0.80

---0.67

-126.81%-0.62

-98.63%-0.41

---0.27

---0.21

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

